Effect of Liraglutide on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Polyvascular Disease: Results of the LEADER Trial

Subodh Verma, Deepak L Bhatt, Stephen C Bain, John B Buse, Johannes F E Mann, Steven P Marso, Michael A Nauck, Neil R Poulter, Richard E Pratley, Bernard Zinman, Marie M Michelsen, Tea Monk Fries, Søren Rasmussen, Lawrence A Leiter, LEADER Publication Committee on behalf of the LEADER Trial Investigators, Subodh Verma, Deepak L Bhatt, Stephen C Bain, John B Buse, Johannes F E Mann, Steven P Marso, Michael A Nauck, Neil R Poulter, Richard E Pratley, Bernard Zinman, Marie M Michelsen, Tea Monk Fries, Søren Rasmussen, Lawrence A Leiter, LEADER Publication Committee on behalf of the LEADER Trial Investigators

No abstract available

Keywords: atherosclerosis; diabetes mellitus, type 2; glucagon-like peptide 1; liraglutide; myocardial infarction.